DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cyclin E1
Cyclin E1
Original Article Expression of Cell-Cycle Regulators Is Associated with Invasive Behavior and Poor Prognosis in Prolactinomas
Mir-15 and Mir-16 Are Direct Transcriptional Targets of E2F1 That Limit E2F-Induced Proliferation by Targeting Cyclin E
Cyclin E2, a Novel Human G1 Cyclin and Activating Partner of CDK2 and CDK3, Is Induced by Viral Oncoproteins
Cyclin-Dependent Kinases and CDK Inhibitors in Virus-Associated Cancers Shaian Tavakolian, Hossein Goudarzi and Ebrahim Faghihloo*
Reduction of Cdc25a Contributes to Cyclin E1-Cdk2 Inhibition at Senescence in Human Mammary Epithelial Cells
Cyclin E1 and Rb Modulation As Common Events at Time of Resistance to Palbociclib in Hormone Receptor-Positive Breast Cancer
Upregulation of CDKN2A and Suppression of Cyclin D1 Gene
Inhibition of CDK4/6 As Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future Perspectives
D3-Deficient Mice Is Compensated by Cyclin D2 in Cyclin of Normal B-1A
Early Adaptation and Acquired Resistance to CDK4/6 Inhibition In
Cyclin E1, GST-Tagged, Human (SRP5345)
Development of a Selective CDK2-E Inhibitor in CCNE-Aberrant Cancers 1279
Cyclin E2 Promotes Whole Genome Doubling in Breast Cancer
The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
Cyclin E1 and Cyclin-Dependent Kinase 2 Are Critical for Initiation, but Not for Progression of Hepatocellular Carcinoma
The Role of Cyclin E in Pkc Iota-Driven Early Ovarian Tumorigenesis
Mammalian Cell-Cycle Regulation: Several Cdks, Numerous Cyclins and Diverse Compensatory Mechanisms
Kinase-Independent Function of E-Type Cyclins in Liver Cancer
Top View
MYC Oncogene Contributions to Release of Cell Cycle Brakes
CDK2/Cycline1 Kinase Assay by Juliano Alves, Ph.D., Dongping Ma, M.S., Said A
Nuclear Receptor NR5A2 Controls Neural Stem Cell Fate Decisions During Development
Overexpression of Cyclin E1 Or Cdc25a Leads to Replication Stress, Mitotic Aberrancies, and Increased Sensitivity to Replication Checkpoint Inhibitors Yannick P
E47 Upregulates Δnp63α to Promote Growth of Squamous Cell Carcinoma
Protein Expression Patterns of Cell Cycle Regulators in Operable Breast Cancer
Cell-Cycle Gene Alterations in 4,864 Tumors Analyzed by Next
Cyclin E1 Deregulation Occurs Early in Secretory Cell Transformation to Promote Formation of Fallopian Tube–Derived High-Grade Serous Ovarian Cancers
Cyclin-Dependent Kinase 4 and 6 Inhibitors in Cell Cycle Dysregulation for Breast Cancer Treatment
Alteration of Gene Expression in Melanoma Cells Following Combined Treatment with E2F-1 and Doxorubicin
Cyclin E1 Inhibition Can Overcome Sorafenib Resistance In
Journal Pre-Proof
Cyclin-Dependent Protein Kinase Inhibitors Including Palbociclib As
Cyclin E1 and Cyclin E2 in ER+ Breast Cancer: Prospects As Biomarkers and Therapeutic Targets
Cyclin E and Cyclin a As Candidates for the Restriction Point Protein1
Cyclin E1 Inhibition Can Overcome Sorafenib Resistance In
Cyclin E1 Expression and Palbociclib
The Ras Oncogene Signals Centrosome Amplification
Simvastatin Induces G1 Arrest by Up-Regulating GSK3β and Down-Regulating CDK4/Cyclin D1 and CDK2/Cyclin E1 in Human P
Upregulation of Cyclin-Dependent Kinase Inhibitors CDKN1B And
CCNE1 Amplification As a Predictive Biomarker of Chemotherapy
Cyclin D As a Therapeutic Target in Cancer
Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor- Positive Metastatic Breast Cancer
Pan-ERBB Kinase Inhibition Augments CDK4/6 Inhibitor Efficacy In
Both Cyclin a and Cyclin E Have S-Phase Promoting (SPF) Activity in Xenopus Egg Extracts
Cul3 Regulates Cyclin E1 Protein Abundance Via a Degron Located
Direct CDKN2 Modulation of CDK4 Alters Target Engagement of CDK4 Inhibitor Drugs
Cyclin E1 and Cyclin-Dependent Kinase 2 Are Critical for Initiation, but Not for Progression of Hepatocellular Carcinoma